BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 34875458)

  • 1. Spatial patterns of brain lesions assessed through covariance estimations of lesional voxels in multiple Sclerosis: The SPACE-MS technique.
    Tur C; Grussu F; De Angelis F; Prados F; Kanber B; Calvi A; Eshaghi A; Charalambous T; Cortese R; Chard DT; Chataway J; Thompson AJ; Ciccarelli O; Gandini Wheeler-Kingshott CAM
    Neuroimage Clin; 2022; 33():102904. PubMed ID: 34875458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accurate GM atrophy quantification in MS using lesion-filling with co-registered 2D lesion masks.
    Popescu V; Ran NC; Barkhof F; Chard DT; Wheeler-Kingshott CA; Vrenken H
    Neuroimage Clin; 2014; 4():366-73. PubMed ID: 24567908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced diffusion-weighted imaging models better characterize white matter neurodegeneration and clinical outcomes in multiple sclerosis.
    Storelli L; Pagani E; Meani A; Preziosa P; Filippi M; Rocca MA
    J Neurol; 2022 Sep; 269(9):4729-4741. PubMed ID: 35397753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periventricular gradient of T
    Vaneckova M; Piredda GF; Andelova M; Krasensky J; Uher T; Srpova B; Havrdova EK; Vodehnalova K; Horakova D; Hilbert T; Maréchal B; Fartaria MJ; Ravano V; Kober T
    Neuroimage Clin; 2022; 34():103009. PubMed ID: 35561554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis.
    Elliott C; Belachew S; Wolinsky JS; Hauser SL; Kappos L; Barkhof F; Bernasconi C; Fecker J; Model F; Wei W; Arnold DL
    Brain; 2019 Sep; 142(9):2787-2799. PubMed ID: 31497864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusely abnormal white matter converts to T2 lesion volume in the absence of MRI-detectable acute inflammation.
    Dadar M; Mahmoud S; Narayanan S; Collins DL; Arnold DL; Maranzano J
    Brain; 2022 Jun; 145(6):2008-2017. PubMed ID: 34927199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple sclerosis lesions in motor tracts from brain to cervical cord: spatial distribution and correlation with disability.
    Kerbrat A; Gros C; Badji A; Bannier E; Galassi F; Combès B; Chouteau R; Labauge P; Ayrignac X; Carra-Dalliere C; Maranzano J; Granberg T; Ouellette R; Stawiarz L; Hillert J; Talbott J; Tachibana Y; Hori M; Kamiya K; Chougar L; Lefeuvre J; Reich DS; Nair G; Valsasina P; Rocca MA; Filippi M; Chu R; Bakshi R; Callot V; Pelletier J; Audoin B; Maarouf A; Collongues N; De Seze J; Edan G; Cohen-Adad J
    Brain; 2020 Jul; 143(7):2089-2105. PubMed ID: 32572488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal Characterization of Cortical Lesion Development and Evolution in Multiple Sclerosis with 7.0-T MRI.
    Treaba CA; Granberg TE; Sormani MP; Herranz E; Ouellette RA; Louapre C; Sloane JA; Kinkel RP; Mainero C
    Radiology; 2019 Jun; 291(3):740-749. PubMed ID: 30964421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. White matter tracts that overlap with the thalamus and the putamen are protected against multiple sclerosis pathology.
    Clarke MA; Archer D; Yoon K; Oguz I; Smith SA; Xu J; Cutter G; Bagnato F
    Mult Scler Relat Disord; 2022 Jan; 57():103430. PubMed ID: 34922252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spatial distribution of multiple sclerosis lesions in the cervical spinal cord.
    Eden D; Gros C; Badji A; Dupont SM; De Leener B; Maranzano J; Zhuoquiong R; Liu Y; Granberg T; Ouellette R; Stawiarz L; Hillert J; Talbott J; Bannier E; Kerbrat A; Edan G; Labauge P; Callot V; Pelletier J; Audoin B; Rasoanandrianina H; Brisset JC; Valsasina P; Rocca MA; Filippi M; Bakshi R; Tauhid S; Prados F; Yiannakas M; Kearney H; Ciccarelli O; Smith SA; Andrada Treaba C; Mainero C; Lefeuvre J; Reich DS; Nair G; Shepherd TM; Charlson E; Tachibana Y; Hori M; Kamiya K; Chougar L; Narayanan S; Cohen-Adad J
    Brain; 2019 Mar; 142(3):633-646. PubMed ID: 30715195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Cortical Lesion Burden on 7-T Magnetic Resonance Imaging With Cognition and Disability in Multiple Sclerosis.
    Harrison DM; Roy S; Oh J; Izbudak I; Pham D; Courtney S; Caffo B; Jones CK; van Zijl P; Calabresi PA
    JAMA Neurol; 2015 Sep; 72(9):1004-12. PubMed ID: 26192316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of gray-matter multiple sclerosis lesions using double inversion recovery, diffusion, contrast-enhanced, and volumetric MRI.
    Parra Corral MA; Govindarajan ST; Stefancin P; Bangiyev L; Coyle PK; Duong TQ
    Mult Scler Relat Disord; 2019 Jun; 31():74-81. PubMed ID: 30951968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep gray matter changes in relapsing-remitting multiple sclerosis detected by multi-parametric, high-resolution magnetic resonance imaging (MRI).
    Al-Radaideh A; Athamneh I; Alabadi H; Hbahbih M
    Eur Radiol; 2021 Feb; 31(2):706-715. PubMed ID: 32851443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinal cord lesions and brain grey matter atrophy independently predict clinical worsening in definite multiple sclerosis: a 5-year, multicentre study.
    Rocca MA; Valsasina P; Meani A; Gobbi C; Zecca C; Barkhof F; Schoonheim MM; Strijbis EM; Vrenken H; Gallo A; Bisecco A; Ciccarelli O; Yiannakas M; Rovira A; Sastre-Garriga J; Palace J; Matthews L; Gass A; Eisele P; Lukas C; Bellenberg B; Margoni M; Preziosa P; Filippi M;
    J Neurol Neurosurg Psychiatry; 2023 Jan; 94(1):10-18. PubMed ID: 36171105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroinflammation and its relationship to changes in brain volume and white matter lesions in multiple sclerosis.
    Datta G; Colasanti A; Rabiner EA; Gunn RN; Malik O; Ciccarelli O; Nicholas R; Van Vlierberghe E; Van Hecke W; Searle G; Santos-Ribeiro A; Matthews PM
    Brain; 2017 Nov; 140(11):2927-2938. PubMed ID: 29053775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative signal properties from standardized MRIs correlate with multiple sclerosis disability.
    Brier MR; Snyder AZ; Tanenbaum A; Rudick RA; Fisher E; Jones S; Shimony JS; Cross AH; Benzinger TLS; Naismith RT
    Ann Clin Transl Neurol; 2021 May; 8(5):1096-1109. PubMed ID: 33943045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glial cell injury and atrophied lesion volume as measures of chronic multiple sclerosis inflammation.
    Jakimovski D; Qureshi F; Ramanathan M; Jalaleddini K; Ghoreyshi A; Dwyer MG; Bergsland N; Weinstock-Guttman B; Zivadinov R
    J Neurol Sci; 2024 Jun; 461():123055. PubMed ID: 38761669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo characterization of cortical and white matter neuroaxonal pathology in early multiple sclerosis.
    Granberg T; Fan Q; Treaba CA; Ouellette R; Herranz E; Mangeat G; Louapre C; Cohen-Adad J; Klawiter EC; Sloane JA; Mainero C
    Brain; 2017 Nov; 140(11):2912-2926. PubMed ID: 29053798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gray matter atrophy is related to long-term disability in multiple sclerosis.
    Fisniku LK; Chard DT; Jackson JS; Anderson VM; Altmann DR; Miszkiel KA; Thompson AJ; Miller DH
    Ann Neurol; 2008 Sep; 64(3):247-54. PubMed ID: 18570297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression of regional atrophy in the left hemisphere contributes to clinical and cognitive deterioration in multiple sclerosis: A 5-year study.
    Preziosa P; Pagani E; Mesaros S; Riccitelli GC; Dackovic J; Drulovic J; Filippi M; Rocca MA
    Hum Brain Mapp; 2017 Nov; 38(11):5648-5665. PubMed ID: 28792103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.